Showing 6001-6010 of 9397 results for "".
- New Personalized Medicine Approach May Help Treat Even the Most Challenging Woundshttps://practicaldermatology.com/news/new-personalized-medicine-approach-to-wound-healing-may-help-treat-even-the-most-challenging-wounds/2458172/An experimental treatment that allows the reprogramming of blood cells to promote the healing process of cutaneous wound may be beneficial in healing challenging wounds. “We discovered a way to modify specific white blood cells – the macrophages – and make them capable o
- ASDS: Nearly 10.5 Million Treatments Performed in 2016https://practicaldermatology.com/news/asds-nearly-105-million-treatments-performed-in-2016/2458171/Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016 – five percent more than 2015 and up 31 percent since 2012, according to the 2016 American Society for Dermatologic Surgery (ASDS) Survey on Dermatologi
- Largest Psoriasis Meta-Analysis to Date Yields New Genetic Clueshttps://practicaldermatology.com/news/largest-psoriasis-meta-analysis-to-date-yields-new-genetic-clues/2458176/A new meta -analysis identifies 16 additional genetic markers that may help researchers get closer to understanding how — and why — psoriasis develops. University of Michigan researchers, working with partners across the globe, published the work in
- Sun Pharma Announces US FDA Filing Acceptance of Biologics License Application For Tildrakizumabhttps://practicaldermatology.com/news/sun-pharma-announces-us-fda-filing-acceptance-of-biologics-license-application-for-tildrakizumab/2458175/The U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Sun Pharma’s tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate-to-severe plaque psoriasis. The
- Tweaking TWEAK May Cool Inflammation in Pso and ADhttps://practicaldermatology.com/news/research-breakthrough-tweak-implicated-in-psoriasis-ad/2458178/New research pinpoints a common driver of skin inflammation in both psoriasis and atopic dermatitis. The findings, published in the May 22, 2017 issue of Nature Communications, showed that TWEAK, a protein related to
- Statement from AAD President Henry W. Lim, MD, FAAD, on the Safety of Sunscreenhttps://practicaldermatology.com/news/statement-from-aad-president-henry-w-lim-md-faad-on-the-safety-of-sunscreen/2458179/“The American Academy of Dermatology wants to emphasize that sunscreen remains a safe, effective form of sun protection. As one component of a daily sun-protection strategy, sunscreen is an important tool in the fight against skin cancer, including melanoma, the deadliest form of skin cance
- Consumer Reports: One-Third of Tested Sunscreens Delivered Less Than Half of Labeled SPF Protectionhttps://practicaldermatology.com/news/consumer-reports-one-third-of-tested-sunscreens-delivered-less-than-half-of-labeled-spf-protection/2458180/For the fifth year in a row, Consumer Reports’ testing has shown that some sunscreens failed to provide the level of protection promised on the package. Of the more than 60 lotions,&nb
- SkinCeuticals Study Finds Antioxidants Protect Against Atmospheric Skin Aginghttps://practicaldermatology.com/news/skinceuticals-study-finds-antioxidants-protect-against-atmospheric-skin-aging/2458181/Exposure to ozone pollution zaps our collagen supply, according to new research from SkinCeuticals in partnership with Professor Giuseppe Valacchi from the University of Ferrara, Italy. After exposure to 0.8ppm ozone, collage
- CVS Pharmacy's New Long Live Skin Campaign Aims to Increase Awareness of Skin Healthhttps://practicaldermatology.com/news/cvs-pharmacys-new-long-live-skin-campaign-aims-to-increase-awareness-of-skin-health/2458183/CVS Pharmacy, the retail division of CVS Health, is rolling out a new multi-platform Long Live Skin campaign to increase awareness about skin health, sun safety and proper skincare. The Long Live Skin Campaign kicks off today online&nbs
- BERG and debra of America Partner to Raise Awareness of EBhttps://practicaldermatology.com/news/berg-and-debra-of-america-partner-to-raise-awareness-of-eb/2458184/Biopharmaceutical company BERG and the non-profit patient advocacy group Dystrophic Epidermolysis Bullosa Research Association of America (debra of America) are partnering up to help patients and families affecte